started · updated
vVardis raises $175 million ahead of NYSE IPO
Dental health firm vVardis has raised $175 million in preparation for its listing on the New York Stock Exchange under the ticker symbol VVVV. The company priced 9.72 million shares at $18 per share.
vVardis specializes in providing the first commercially available peptide-containing formulation designed to treat early cavities without the need for drilling. Co-founders and Co-CEOs Dr. Haley Abivardi and Dr. Goly Abivardi are scheduled to discuss the company’s transition to a public entity on NYSE Live.
Entities
Dr. Goly Abivardi · Dr. Haley Abivardi · New York Stock Exchange · vVardis